Steven L. Tuch - 27 Feb 2024 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Chief Financial Officer
Signature
/s/ Paul J. Sekhri as Attorney-in-Fact
Issuer symbol
VTVT
Transactions as of
27 Feb 2024
Net transactions value
+$734,098
Form type
4
Filing time
13 Jun 2024, 16:38:28 UTC
Previous filing
13 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTVT Employee stock option (right to buy) Award $734,098 +62,159 +497% $11.81 74,659 27 Feb 2024 Class A Common Stock 62,159 $11.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in quarterly equal installments over the three year period beginning on February 27, 2024. The option was conditioned upon shareholder approval of the 2024 Equity Incentive Plan, which was approved by the shareholders on June 11, 2024.